Is There An Upcoming Recession? U.S. Money Reserve Have A Say About This Matter

Economic Recessions and Depressions are one of the darkest parts of US history. Although there are a lot of recessions worst than the others, all of the recessions were marked by hard times.

As of now, no one seems to agree that there is a possibility for a recession in the current economy. After all, unemployment is 4%, the stock market is currently bullish, and some of the states saw a drop in the price of some important commodities. The U.S. Money Reserve, however, saw this time as one of the most challenging ones.

There is no escaping when a recession comes because it is a part of the economic cycle. People, especially the government and the businesses, will have to deal with it. Signs of a recession are high unemployment, and the slowdown of economic activities, both borrowings, and spendings.

Another one of the indicators is when the US Federal Reserve tries to raise the interest rates to slow down borrowings. Both the government and financial institutions will try to delay the inevitable, but the longer they delay the upcoming recession, the harder it will hit both individuals and corporations.

The 120th Month Mark

One of the strongest indicators that economic experts are watching right now is the 120th-month mark which was a hidden indicator of the 1990s recession. The dot.com bubble has been in a very favorable situation until it reached the 120th bullish month. People became very optimistic because the market has been bullish for so long.

Assets became overvalued and burst in front of their eyes when correction finally happened in the 120th month. We are currently in the 100th month of bullish activity, and a lot of economists and investors are on the watch. Reaching the 120th mark might trigger an uncertainty that can cause the slowdown of economic growth.

People who are paying their mortgages will be the first one to feel the effect if the recession happened. It can be remembered that it has only been a decade after the 2008 financial crisis and only a few years before the economy recovered back to its state before the crisis.

The debt recorded is almost as high as the debt level that was recorded before the crisis appeared. In addition, there is a tense atmosphere between the Republicans and the Democrats right now in politics. Read more: US Money Reserve | Biz Journals and US Money Reserve | Manta

Back then, both the Democrats and the Republicans are joined forces to sign the Troubled Asset Relief Program and the American Recovery and Reinvestment Act, which helped the crisis. Right now, the collaboration seems unlikely.

If there is a particular asset that still appraises in value during a crisis, that would be gold and other precious metals. During the last recession between 2007 to 2009, gold is one of the handfuls of assets that rose in valuation. In fact, the rose valuation went up by 26% and buying gold has been one of the ways to leverage the damage.

As of now, the leading supplier of gold and other precious metals is the U.S. Money Reserve. It is currently led by Philip N. Diehl, who was the 35th director of the US Mint back from 1994 to 2000. The company has been in operation since 2001.

Connect with US Reserve on LinkedIn

Click on the links below to learn more about US Money Reserve:

Why Buy Gold

https://www.indeed.com/cmp/U.S.-Money-Reserve

“Marc Beer to guide LumeNXT as the board chairman “

LumeNXT is a new med-tech startup that is developing proprietary illumination technology. This technology is being used in making minimally invasive surgeries. With a promising technology, LumeNXT is expected to become a great med-tech company in coming days. They have now hired the services of Marc Beer, a notable name in the industry who has helped several startups to get global recognition as well as profitability in a very short time. What the company needs right now is an experienced leader who can guide its operations going forward. There is no better person to help the company than Marc Beer. He has been appointed the chairman of the board of LumeNXT, and now will guide the company as it targets to introduce a product line that will make it easier to perform surgeries with minimally invasive procedures.

LumeNXT was impressed by the track record of Marc Beer. He has managed to start and grow startups within a very short time. It is such track record that impressed LumeNXT who saw him as the best person to lead the company. He has been in similar situations many times and in all, he has come out victorious. Marc Beer is impressed by the illumination technology coming from this company because it will bring great efficiency and precision into the medical industry. The fact that visibility is enhanced makes it possible for doctors to perform minimally invasive procedures with far much better accuracy.

Marc Beer has over 25 years of experience in different fields of the healthcare industry. He has worked in pharmaceuticals, diagnostics, devices, biotechnology, and others. He has seen how startups come and collapse after a short time and have learned how to build strong businesses. It is very hard for medical startups to succeed, but Marc Beer has record success with all the startups he has guided.

Marc Beer at Renovia

Marc Beer is the co-founder and current CEO of Renovia Inc., a medtech startup based in Boston. He started this startup in 2016 and has since made significant efforts towards making it one of the best companies in the medical sector. Renovia is developing solutions for women affected by pelvic floor disorders. These are challenges that affect over 250 million women around the world. Learn more: https://www.linkedin.com/in/marcbeerRenovia Inc. has done pretty well as a company in the past two years. It has attracted leading investors in the healthcare industry such as the Longwood Fund. Investors see the idea as one that will succeed in the long run since we are in a baby boomer period where cases of pelvic floor disorders will continue to increase. LumeNXT is hoping to benefit from the exceptional leadership skills that Marc Beer possesses also to have a brighter future.

Marc Beer’s brilliance in the healthcare industry in a giant leap forward for women with pelvic floor disorders

A start-up company by the name of Renovia Inc. will be moving forward after closing a $32 million dollar deal with several new products for pelvic floor disorders. This new business deal also included a venture debt for $10 million dollars. This start-up company was co-founded by Marc Beer, a former Aegerion Pharmaceuticals CEO.

 

This med-tech company is based out of Boston. This company is developing a variety of therapeutic and diagnostic products to treat things such as urinary incontinence, a pelvic floor disorder that affects 250 million women globally. Leva was the Renovia Company’s first products. This product received FDA approval in the month of April.

A healthcare-focused investing firm that invested early on in the start-up company was the Longwood Fund. The Longwood Fund and Series B round was joined by the Missouri-Based Ascension Venture and the New York Based Perceptive Advisors. Their financial support with this business venture will go towards testing and developing several more diagnostic and therapeutic products, a new Leva product will be included.

 

Marc Beer stated that by combing proprietary and innovative form factors and sensor technologies with a healthcare digital platform would give their clients and/or customers valuable information to advise new options for treatments, understanding pelvic floor disorders, ultimately lower long-term costs for healthcare and drive greater knowledge. Beer stated that he and the company are thrilled with this leading healthcare investor group’s assistance that actually share their mission to treat, better diagnose and actually improve the millions off women’s lives who are affected with the disorders of the pelvic floor.

 

A response was not given by the company regarding its pipeline of products or its investments.

 

Marc Beer’s first business venture is Renovia since leaving Aegerion in the year of 2015. Beer brings over 25 years of commercialization and development in pharmaceuticals, biotechnology, diagnostics and devices. Beer and Ramon Iglesias MD as well as Yolanda Lorie founded Renovia in August 2016. All three successfully obtained financing for the closure of Series A with venture leading healthcare capital funds.

 

OvaScience (Nasdaq: OVAS) also has Beer serve as a strategic consultant. A business merger will also be taking place between Michigan-based Millendo Therapeutics and Waltham Biotech.

Learn more: https://renoviainc.com/